-benzyl analogues selectively furnish sulfonylative spiro-γ-lactams. The method tolerates diverse radical precursors, offers a broad scope, and is supported by mechanistic studies including radical trapping, isotope labeling, and DFT analysis. Selected products show notable antibacterial and antifungal activity, highlighting the therapeutic potential of the resulting S(VI) scaffolds.
Vishwakarma et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: